The use of FDG-PET to guide consolidative radiotherapy in patients with advanced-stage Hodgkin lymphoma with residual abnormalities on CT scan following ABVD chemotherapy

被引：0
|
作者：
Savage, K. J.
Connors, J. M.
Klasa, R. J.
Hoskins, P.
Shenkier, T. N.
Gascoyne, R. D.
Bhimji, S.
Pickles, T.
Benard, F.
Wilson, D.
Sehn, L. H.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 4E6, Canada
[3] British Columbia Canc Agcy, Dept Radiol, Vancouver, BC V5Z 4E6, Canada
[4] British Columbia Canc Agcy, Dept Nucl Med, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8034
引用
收藏
页数：1
相关论文
共 50 条
  • [31] FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Klaskova, K.
    Dedeckova, K.
    Plutschow, A.
    Eich, H. T.
    Dietlein, M.
    Engert, A.
    Kozak, T.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1270 - 1274
  • [32] EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Zikavska, L.
    Vernerova, Z.
    Klaskova, K.
    Dedeckova, K.
    Eich, H. T.
    Dietlein, M.
    Fuchs, M.
    Engert, A.
    Kozak, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 33 - 33
  • [33] Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (01) : 129 - 131
  • [34] Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
    Girinskya, Theodore
    Ghalibafian, Mithra
    Bonniaud, Guillaume
    Baya, Aziz
    Magne, Nicolas
    Ferreira, Ivaldo
    Lumbroso, Jean
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (02) : 178 - 186
  • [35] PET2-Adapted Therapy in Patients With Advanced-Stage Hodgkin Lymphoma Treated With Frontline ABVD: Searching for the Baby in the Bathwater
    Pinto, Antonio
    Cuccaro, Annarosa
    Bonanni, Matteo
    Fresa, Alberto
    Filippi, Rosaria De
    Corazzelli, Gaetano
    HEMATOLOGICAL ONCOLOGY, 2025, 43 (01)
  • [36] Combined escBEACOPP-ABVD therapy for advanced Hodgkin's lymphoma patients with high IPS score: An effective regimen and low positive predictive value of early FDG-PET/CT scan
    Avigdor, Abraham
    Bulvik, Shlomo
    Dann, Eldad
    Levi, Itai
    Perez-Avraham, Galit
    Shemtov, Noga
    Shimoni, Avichai
    Nagler, Arnon
    Ben-Bassat, Isaac
    Polliack, Aaron
    BLOOD, 2007, 110 (11) : 686A - 686A
  • [37] Metabolic effects of chemotherapy on the brain in Non-Hodgkin Lymphoma (NHL) patients as measured on FDG-PET/CT
    Saboury, B.
    JinHyung, A. A.
    Hofheinz, F.
    Alavi, A.
    Torigian, D. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S427 - S427
  • [38] Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy
    Simontacchi, Gabriele
    Filippi, Andrea Riccardo
    Ciammella, Patrizia
    Buglione, Michela
    Saieva, Calogero
    Magrini, Stefano Maria
    Livi, Lorenzo
    Iotti, Cinzia
    Botto, Barbara
    Vaggelli, Luca
    Re, Alessandro
    Merli, Francesco
    Ricardi, Umberto
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (05): : 1077 - 1083
  • [39] Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy
    Adams, Hugo J. A.
    Kwee, Thomas C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : 724 - 725
  • [40] EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD
    Fiore, F.
    Viviani, S.
    Luminari, S.
    Levis, A.
    Di Raimondo, F.
    Merli, F.
    Vitolo, U.
    Bolis, S.
    Federico, M.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S18 - S18
12345